NASDAQ:ACXP

Acurx Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy ACXP

*Your capital is at risk

$1.75

-0.0500 (-2.78%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ACXP Prediction Chart

ACXP Predictions History

Latest community submissions for ACXP.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Jan 30, 2024	$3.83 +4.19%	$3.55	X	92.00%	0
PredictionBot.Warren Pro	Jan 30, 2024	$3.78 +2.62%	$3.55	X	93.62%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ACXP with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ACURX PHARMACEUTICALS, INC.

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bac...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by